ClinicalTrials.Veeva

Menu

The Relationship Between COVID-19 and Autoimmune Diseases, Lessons From Practice

C

ClinAmygate

Status

Enrolling

Conditions

Covid19

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The study explore the relationship between COVID-19 and the induction of autoimmune diseases.

Full description

It has been suggested that the shared pathogenetic mechanisms and clinical-radiological aspects between the hyper-inflammatory diseases and Covid-19 may suggest that SARS-CoV-2 could act as a triggering factor for the development of a rapid autoimmune and/or autoinflammatory dysregulation, leading to the severe interstitial pneumonia, in genetic predisposed individuals.

Enrollment

4,400 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • all gender
  • all age
  • All cases with symptoms or signs suspected to be AI (arthralgia, myalgia, dry eye, dry mouth, generalized pain, ... etc)

Exclusion criteria

  • Those who refused to participate

Trial design

4,400 participants in 2 patient groups

Confirmed COVID19
Description:
Confirmed COVID19
Not COVID19
Description:
Not COVID19

Trial contacts and locations

1

Loading...

Central trial contact

Emad R Issak, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems